top of page
Thrombosis questions from the inpatient wards
Goshua G, Bendapudi PK, Lee AI
Hematology Am Soc Hematol Educ Program
December
2022
Association of iron infusion reactions with ABO blood type
Butt A, Muradashvili T, Soliman S, Li F, Burns AJ, Brooks A, Browning S, Bar N, Borgman G, Goshua G, Hwa J, Martin K, Rinder H, Tormey C, Pine AB, Bona RD, Lee AI, Neparidze N
Eur J Haematol
November
2022
Adenovirus-based vaccines and thrombosis in pregnancy: a systematic review and meta-analysis.
Pischel L, Patel K, Goshua G, Omer S
Clinical Infectious Diseases
September
2022
Reduced fixed dose tocilizumab 400mg IV compared to weight-based dosing in critically ill patients with COVID-19: a before-after cohort study
Goshua G (co-first), Stukas S, Kinkade A, Grey R, Mah G, Biggs CM, Jamal S, Thiara S, Lau T, Piszczek J, Partovi N, Sweet DD, Lee AYY, Wellingon CL, Sekhon MS, Chen LYC
The Lancet Regional Health- Americas
July
2022
Gap: Time-sensitive, factual-counterfactual cost-effectiveness analysis informing provincial resource allocation in a resource-constrained setting during pandemic peaks.

Gap: Time-sensitive, factual-counterfactual cost-effectiveness analysis informing provincial resource allocation in a resource-constrained setting during pandemic peaks.

Cost-effectiveness of liposomal cytarabine/daunorubicin in patients with newly diagnosed acute myeloid leukemia
Bewersdorf J, Patel K, Goshua G, Shallis R, Podoltsev N, Huntington S, Zeidan A
Blood
March
2022
Cost-effectiveness of tocilizumab in severe COVID- 19: to see or not to see
Pischel L and Goshua G
Clinical Infectious Diseases
December
2021
Immunothrombosis: a COVID-19 concerto
Goshua G, Butt A, Lee AI
British Journal of Haematology
August
2021
Increased complement activation is a distinctive feature of severe SARS- CoV-2 infection
Ma L, Sahu Sk, Cano M, Kuppuswamy V, Bajwa J, McPhatter J, Pine A, Meizlish ML, Goshua G, Chang C, Zhang H, Price C, Bahel P, Rinder H, Lei T, Day A, Reynolds D, Wu X, Schriefer R, Rauseo AM, Goss CW, O’Halloran JA, Presti RM, Kim AH, Gelman AE, Dela Cruz CS, Lee AI, Mudd PA, Chun HJ, Atkinson JP, Kulkarni HS
Science Immunology
May
2021

Featured Publications (5)

All Selected Publications

Thrombosis questions from the inpatient wards
Goshua G, Bendapudi PK, Lee AI
Hematology Am Soc Hematol Educ Program
2022
December
RECOGNITIONS:

PRACTICAL IMPACT:
Association of iron infusion reactions with ABO blood type
Butt A, Muradashvili T, Soliman S, Li F, Burns AJ, Brooks A, Browning S, Bar N, Borgman G, Goshua G, Hwa J, Martin K, Rinder H, Tormey C, Pine AB, Bona RD, Lee AI, Neparidze N
Eur J Haematol
2022
November
RECOGNITIONS:

PRACTICAL IMPACT:
Adenovirus-based vaccines and thrombosis in pregnancy: a systematic review and meta-analysis.
Pischel L, Patel K, Goshua G, Omer S
Clinical Infectious Diseases
2022
September
RECOGNITIONS:

PRACTICAL IMPACT:
Reduced fixed dose tocilizumab 400mg IV compared to weight-based dosing in critically ill patients with COVID-19: a before-after cohort study
Goshua G (co-first), Stukas S, Kinkade A, Grey R, Mah G, Biggs CM, Jamal S, Thiara S, Lau T, Piszczek J, Partovi N, Sweet DD, Lee AYY, Wellingon CL, Sekhon MS, Chen LYC
The Lancet Regional Health- Americas
2022
July
RECOGNITIONS:

Gap: Time-sensitive, factual-counterfactual cost-effectiveness analysis informing provincial resource allocation in a resource-constrained setting during pandemic peaks.

PRACTICAL IMPACT:
Cost-effectiveness of liposomal cytarabine/daunorubicin in patients with newly diagnosed acute myeloid leukemia
Bewersdorf J, Patel K, Goshua G, Shallis R, Podoltsev N, Huntington S, Zeidan A
Blood
2022
March
RECOGNITIONS:

PRACTICAL IMPACT:
Cost-effectiveness of tocilizumab in severe COVID- 19: to see or not to see
Pischel L and Goshua G
Clinical Infectious Diseases
2021
December
RECOGNITIONS:

PRACTICAL IMPACT:
Immunothrombosis: a COVID-19 concerto
Goshua G, Butt A, Lee AI
British Journal of Haematology
2021
August
RECOGNITIONS:

PRACTICAL IMPACT:
Increased complement activation is a distinctive feature of severe SARS- CoV-2 infection
Ma L, Sahu Sk, Cano M, Kuppuswamy V, Bajwa J, McPhatter J, Pine A, Meizlish ML, Goshua G, Chang C, Zhang H, Price C, Bahel P, Rinder H, Lei T, Day A, Reynolds D, Wu X, Schriefer R, Rauseo AM, Goss CW, O’Halloran JA, Presti RM, Kim AH, Gelman AE, Dela Cruz CS, Lee AI, Mudd PA, Chun HJ, Atkinson JP, Kulkarni HS
Science Immunology
2021
May
RECOGNITIONS:

PRACTICAL IMPACT:

Prophylactic weekly efanesoctocog alfa versus standard-care factor VIII in people living with severe hemophilia A: a cost-effectiveness analysis

Ito S, Potnis KC, Harvey JP, Sra M, Bewersdorf JP, Bona RD, Krumholz HM, Cuker A, Pandya A, Goshua G.
Annals of Internal Medicine
2025
June
FEATURED
RECOGNITIONS:

Gap: First conventional and distributional cost-effectiveness analysis in the care of people living with hemophilia A (Yale-HSPH-Mayo-Penn collaboration). ASH Abstract Achievement Award (S. Ito).

PRACTICAL IMPACT:

Cost-effectiveness of Lynch syndrome screening in colorectal cancer: universal germline vs sequential screening

Ito S, Xicola RM, Sra M, Potnis KC, Singh V, Gershkovich P, Stites E, Gibson J, Krumholz HM, Llor X, Goshua G
Clinical Gastroenterology & Hepatology
2025
April
FEATURED
RECOGNITIONS:

Gap: Real-world diagnostic attrition leads to missed diagnoses of inherited Lynch syndrome in probands with colorectal cancer (CRC) and their relatives. Health economic rationale for upfront germline tumor testing in probands to improve population health.

PRACTICAL IMPACT:

Cost-effectiveness of ferritin screening thresholds for iron deficiency in reproductive-age women

Wang D, Sra M, Glaeser-Khan S, Wang DY, Moshashaian-Asl R, Ito S, Cuker A, Goshua G
American Journal of Hematology
2025
April
FEATURED
RECOGNITIONS:

Gap: First cost-effectiveness analysis of ferritin screening thresholds in the care of people living with iron deficiency (Yale-Mayo-Vermont-Penn collaboration). 2024 ASH Press Program Selection, 2025 Highlights of ASH, ASH Abstract Achievement Award (D. Wang).

PRACTICAL IMPACT:

Cost-effectiveness of iptacopan for paroxysmal nocturnal hemoglobinuria

Ito S*, Chetlapalli K*, Wang D, Potnis KC, Richmond R, Krumholz H, Lee AI, Cuker A, Goshua G.
Blood
2025
January
FEATURED
RECOGNITIONS:

Gap: Proximal complement inhibition is cost-saving for patients with suboptimal response on C5 inhibitor therapy in the United States and can be cost-saving in international jurisdictions (Penn-Yale collaboration).

PRACTICAL IMPACT:

Decreasing alloimmunization-specific mortality in sickle cell disease in the United States: Cost-effectiveness of a shared transfusion resource

Ito S, Pandya A, Hauser RG, Krishnamurti L, Stites E, Tormey C, Krumholz HM, Hendrickson JE, Goshua G
American Journal of Hematology
2024
April
FEATURED
RECOGNITIONS:

Gap: Supporting the mission of the 501(c)(3) Alloantibody Exchange www.alloantibody.org. 2022 ASH Press Program Selection.

PRACTICAL IMPACT:
Abstract Futuristic Background

Publications

bottom of page